Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse

Marian Gómez-Beldarrain1, María Carrasco, Amaia Bilbao

  • 1Service of Neurology, Hospital de Galdacano, 48960 Galdacano, Vizcaya, Spain. mgomezab@sarenet.es

Insights

Chronic migraine patients with medication overuse show orbitofrontal dysfunction, linked to poor outcomes. Neuropsychological tests may identify those at risk for overuse, aiding early intervention.

Area of Science:

  • Neuroscience
  • Neurology
  • Psychology

Background:

  • Chronic migraine patients face medication overuse risks.
  • Orbitofrontal hypometabolism is observed in these patients, persisting post-cessation.
  • Orbitofrontal dysfunction's link to addiction suggests a predisposition to medication overuse in migraineurs.

Purpose of the Study:

  • To investigate orbitofrontal dysfunction in chronic migraine with medication overuse via neuropsychological evaluation.
  • To determine if orbitofrontal dysfunction correlates with patient outcomes.
  • To assess frontal lobe function and its relation to medication overuse and treatment success.

Main Methods:

  • Prospective study of 42 chronic migraine with medication overuse patients, 42 episodic migraineurs, and 41 controls.
  • Utilized a neuropsychological test battery assessing orbitofrontal and dorsolateral frontal lobe functions.
  • Assessed depression, anxiety, and personality traits; followed patients for 1-year outcomes.

Main Results:

  • Chronic migraine with medication overuse patients exhibited significant orbitofrontal impairment and higher depression scores.
  • Dorsolateral dysfunction was noted in both migraine groups, with higher anxiety than controls.
  • Poor 1-year outcome (persistent/new medication overuse) in 34% correlated with baseline orbitofrontal dysfunction, mild dorsolateral dysfunction, and higher depression/anxiety/neuroticism.

Conclusions:

  • Orbitofrontal dysfunction is present in chronic migraine with medication overuse.
  • This dysfunction predicts poor patient outcomes at 1-year follow-up.
  • Neuropsychological evaluation can identify patients prone to medication overuse, guiding therapeutic strategies.